Commure raised $70 million at a $7 billion post-money valuation Tuesday, with General Catalyst leading and Sequoia Capital, Morgan Stanley, and Kirkland & Ellis participating.
General Catalyst isn’t a new investor here. It previously led a $200M growth financing round for Commure’s revenue cycle platform. Coming back at a $7B cap signals conviction the market is real, not just the pitch.
What does the buyer actually get? Commure’s revenue cycle platform runs across more than 500 healthcare organizations and 3,000+ care sites, including HCA Healthcare and Tenet Healthcare. It processes tens of billions of dollars in annual payments and completes more than 85% of that work without human intervention. The pitch: it’s replacing the billing department, not staffing it.
The $1 trillion annual administrative cost burden in U.S. healthcare is the market. CEO Tanay Tandon says AI can now do what thirty years of software couldn’t: the calls, the notes, the codes, the claims, the denials and the appeals.
Commure enters an active billing arms race. Insurers have flagged sudden spikes in severe diagnoses they attribute to AI-enabled coding by providers. HCA Healthcare executives have said the tools are essential to counter growing denial and underpayment activity from payers. At $7 billion, investors are betting the hospital side wins.
New capital goes toward scaling its revenue cycle and practice management platforms and international expansion. Whether payers let hospitals keep the AI coding edge is the real question.
Diana Kowalski